Carregant...
Glioblastoma-targeted CD4(+) CAR T cells mediate superior antitumor activity
Chimeric antigen receptor–modified (CAR-modified) T cells have shown promising therapeutic effects for hematological malignancies, yet limited and inconsistent efficacy against solid tumors. The refinement of CAR therapy requires an understanding of the optimal characteristics of the cellular produc...
Guardat en:
| Publicat a: | JCI Insight |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012522/ https://ncbi.nlm.nih.gov/pubmed/29769444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.99048 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|